Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2017-06-14 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTPELLIER (34090), Herault
SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS : revenue, balance sheet and financial ratios
SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTPELLIER (34090),
this company of category PME
shows in 2023 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS (SIREN 830276457)
Indicator
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
1 798 324 €
N/C
N/C
N/C
N/C
1 212 829 €
Net income
109 765 €
115 104 €
130 651 €
92 065 €
54 205 €
100 015 €
-47 197 €
EBITDA
N/C
153 829 €
N/C
N/C
N/C
N/C
-45 859 €
Net margin
N/C
6.4%
N/C
N/C
N/C
N/C
-3.9%
Revenue and income statement
In 2024, SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS generates positive net income of 110 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
109 765 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 118%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
117.817%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.224%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Debt ratio
-2847.576
1565.084
804.257
420.971
221.149
160.613
117.817
Financial autonomy
-3.222
5.288
9.75
16.551
26.609
33.576
41.224
Repayment capacity
-20.706
None
None
None
None
6.473
None
Cash flow / Revenue
-4.218%
None%
None%
None%
None%
6.276%
None%
Sector positioning
Debt ratio
117.822024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-10 pts over 3 years
In 2024, the debt ratio of SELARL BOURBON DEBERNARD ... (117.82) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.22%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+15 pts over 3 years
In 2024, the financial autonomy of SELARL BOURBON DEBERNARD ... (41.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
6.47 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of SELARL BOURBON DEBERNARD ... (6.47) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 188.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
188.422
Liquidity indicators evolution SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
116.11
130.863
135.547
0.0
0.0
160.252
188.422
Interest coverage
-12.787
None
None
None
None
2.543
None
Sector positioning
Liquidity ratio
188.422024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+50 pts over 3 years
In 2024, the liquidity ratio of SELARL BOURBON DEBERNARD ... (188.42) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.54x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of SELARL BOURBON DEBERNARD ... (2.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Operating WCR
102 193 €
0 €
0 €
0 €
0 €
185 785 €
0 €
Inventory turnover (days)
29
0
0
0
0
29
0
Customer payment term (days)
3
0
0
0
0
2
0
Supplier payment term (days)
35
0
0
0
0
40
0
Positioning of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS is estimated at
1 532 400 €
(range 1 067 139€ - 2 292 558€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1067k€1532k€2292k€
1 532 400 €Range: 1 067 139€ - 2 292 558€
NAF 5 année 2024
Valuation method used
Net Income Multiple
109 765 €
×
14.0x
=1 532 401 €
Range: 1 067 140€ - 2 292 559€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS with other companies in the same sector:
Frequently asked questions about SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS
What is the revenue of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS ?
The revenue of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS in 2023 is 1.8 M€.
Is SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS profitable?
Yes, SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS generated a net profit of 110 k€ in 2024.
Where is the headquarters of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS ?
The headquarters of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS is located in MONTPELLIER (34090), in the department Herault.
Where to find the tax return of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS ?
The tax return of SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS operate?
SELARL BOURBON DEBERNARD PHARMACIE DES BEAUX ARTS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart